
After a brief introduction, medical experts discuss advances in MDS classification and molecular understanding.
After a brief introduction, medical experts discuss advances in MDS classification and molecular understanding.
Medical experts discuss risk-based approaches to choosing MDS therapies.
Medical experts offer insights on the COMMANDS trial findings.
Medical experts discuss the data gathered from the ASCERTAIN trial.
Medical experts discuss convenience and efficacy in higher-risk MDS regarding oral vs injectable HMAs.
Medical experts offer insights on the persistence and effectiveness of HMAs in patients with higher-risk MDS.
Medical experts discuss innovations and future directions in treatments for higher-risk MDS.
Medical experts discuss innovations and future directions in treatments for higher-risk MDSMedical experts offer patient perspectives on advantages and disadvantages of using oral HMAs vs injectable HMAs.
Medical experts discuss considerations and patient guidance for oral and IV HMAs.
Medical experts offer their insights and closing remarks regarding patient feedback for MDS.
259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.